Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3520LO3W
Performance in the last:
Follow this Portfolio
1D 0.0 %
1W -0.3 %
2W -0.4 %
1M 1.0 %
3M 3.2 %
6M 7.1 %
9M 9.5 %
1Y 15.7 %
Alpha
6.1%
Beta
0.54
sharpe-R
0.9
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
1.8
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2025-02-18 07:00:59
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -9.69%
Max. DrawDown Benchmark -8.41%

This Long Only strategy aims to find promising assets to invest in for a maximum holding period of 3 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 20.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
2
Difficulty Level
2

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
** The description of each asset is available Here

The latest 5 Compositions change

2025-02-11 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All -15.67%
Assets Rebalanced
None
2025-02-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 4.08% -8.62%
The percentage of cash held in the portfolio is: 95.92%
New Assets Added
None
Assets Removed
Asset Action Perf %
BLFS Sell All -7.77%
Assets Rebalanced
None
2025-02-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 4.35% -2.35%
BLFS BioLife Solutions, Inc. Buy 4.04% -7.46%
The percentage of cash held in the portfolio is: 91.61%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All 6.61%
Assets Rebalanced
None
2025-02-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 4.97% 8.11%
AGEN Agenus Inc. Buy 4.52% 1.83%
BLFS BioLife Solutions, Inc. Buy 4.1% -5.58%
The percentage of cash held in the portfolio is: 86.41%
New Assets Added
None
Assets Removed
Asset Action Perf %
MD Sell All -0.14%
MDXG Sell All -3.17%
NVRO Sell All 18.4%
LGND Sell All 6.37%
AXSM Sell All 21.6%
CERS Sell All 1.62%
DNLI Sell All 9.72%
ATXS Sell All -2.31%
RGNX Sell All 13.31%
ANIP Sell All 5.76%
Assets Rebalanced
None
2025-02-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
MD Pediatrix Medical Group, Inc. Buy 4.78% -0.64%
MDXG MiMedx Group, Inc. Buy 4.67% -3.06%
NVRO Nevro Corp. Buy 5.82% 20.99%
LGND Ligand Pharmaceuticals Incorporated Buy 5.12% 6.33%
AXSM Axsome Therapeutics, Inc. Buy 5.8% 20.45%
CERS Cerus Corporation Buy 4.84% 0.54%
DNLI Denali Therapeutics Inc. Buy 5.15% 6.93%
ATXS Astria Therapeutics, Inc. Buy 4.65% -3.47%
RGNX REGENXBIO Inc. Buy 5.45% 13.31%
ANIP ANI Pharmaceuticals, Inc. Buy 4.99% 3.61%
ORGO Organogenesis Holdings Inc. Buy 4.85% 4.5%
AGEN Agenus Inc. Buy 4.1% -8.62%
BLFS BioLife Solutions, Inc. Buy 4.08% -6.96%
The percentage of cash held in the portfolio is: 35.7%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Sell All 52.16%
ACRS Sell All 0.4%
Assets Rebalanced
None
2025-02-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 7.5% 53.16%
ACRS Aclaris Therapeutics, Inc. Buy 4.7% -4%
MD Pediatrix Medical Group, Inc. Buy 4.87% -0.57%
MDXG MiMedx Group, Inc. Buy 4.74% -3.17%
NVRO Nevro Corp. Buy 5.75% 17.45%
LGND Ligand Pharmaceuticals Incorporated Buy 5.1% 4.06%
AXSM Axsome Therapeutics, Inc. Buy 5.61% 14.59%
CERS Cerus Corporation Buy 4.76% -2.7%
DNLI Denali Therapeutics Inc. Buy 4.97% 1.58%
ATXS Astria Therapeutics, Inc. Buy 4.67% -4.62%
RGNX REGENXBIO Inc. Buy 5.15% 5.11%
ANIP ANI Pharmaceuticals, Inc. Buy 5.01% 2.4%
ORGO Organogenesis Holdings Inc. Buy 4.83% 2.4%
AGEN Agenus Inc. Buy 4.18% -8.36%
BLFS BioLife Solutions, Inc. Buy 4.2% -5.94%
The percentage of cash held in the portfolio is: 23.94%
New Assets Added
None
Assets Removed
Asset Action Perf %
AXGN Sell All -1.81%
INSM Sell All 12.98%
SIGA Sell All -9.55%
Assets Rebalanced
None
2025-02-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 4.78% -0.22%
INSM Insmed Incorporated Buy 5.32% 11.1%
NUTX Nutex Health Inc. Buy 7.14% 48.84%
ACRS Aclaris Therapeutics, Inc. Buy 4.76% -0.8%
MD Pediatrix Medical Group, Inc. Buy 4.79% -0.14%
MDXG MiMedx Group, Inc. Buy 4.73% -1.36%
NVRO Nevro Corp. Buy 5.73% 19.58%
LGND Ligand Pharmaceuticals Incorporated Buy 5.07% 5.69%
AXSM Axsome Therapeutics, Inc. Buy 5.44% 13.56%
CERS Cerus Corporation Buy 4.85% 1.08%
DNLI Denali Therapeutics Inc. Buy 5.2% 8.37%
ATXS Astria Therapeutics, Inc. Buy 4.84% 0.9%
RGNX REGENXBIO Inc. Buy 5.2% 8.47%
ANIP ANI Pharmaceuticals, Inc. Buy 4.97% 3.7%
ORGO Organogenesis Holdings Inc. Buy 5.11% 10.51%
AGEN Agenus Inc. Buy 4.43% -0.78%
SIGA SIGA Technologies, Inc. Buy 3.55% -6.42%
BLFS BioLife Solutions, Inc. Buy 4.22% -3.5%
The percentage of cash held in the portfolio is: 9.89%
New Assets Added
None
Assets Removed
Asset Action Perf %
CPRX Sell All -5.84%
TGTX Sell All -0.69%
Assets Rebalanced
None
2025-01-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
AXGN AxoGen, Inc. Buy 4.8% 0.33%
INSM Insmed Incorporated Buy 5.42% 13.16%
NUTX Nutex Health Inc. Buy 6.7% 39.94%
ACRS Aclaris Therapeutics, Inc. Buy 4.52% -5.6%
MD Pediatrix Medical Group, Inc. Buy 4.85% 1.36%
MDXG MiMedx Group, Inc. Buy 4.91% 2.61%
NVRO Nevro Corp. Buy 5.71% 19.34%
LGND Ligand Pharmaceuticals Incorporated Buy 5.16% 7.83%
AXSM Axsome Therapeutics, Inc. Buy 5.37% 12.15%
CERS Cerus Corporation Buy 5.02% 4.86%
DNLI Denali Therapeutics Inc. Buy 5.21% 8.88%
ATXS Astria Therapeutics, Inc. Buy 4.58% -4.24%
RGNX REGENXBIO Inc. Buy 4.84% 1.08%
ANIP ANI Pharmaceuticals, Inc. Buy 5.02% 4.95%
ORGO Organogenesis Holdings Inc. Buy 5.27% 14.11%
AGEN Agenus Inc. Buy 4.2% -5.74%
SIGA SIGA Technologies, Inc. Buy 3.71% -2.03%
TGTX TG Therapeutics, Inc. Buy 3.97% 4.54%
BLFS BioLife Solutions, Inc. Buy 4.36% 0%
CPRX Catalyst Pharmaceuticals, Inc. Buy 4.36% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • BLFS
  • CPRX
Assets Removed
Asset Action Perf %
AORT Sell All 3.27%
Assets Rebalanced
None
2025-01-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 4.87% 1.36%
AXGN AxoGen, Inc. Buy 4.72% -1.75%
INSM Insmed Incorporated Buy 5.41% 12.62%
NUTX Nutex Health Inc. Buy 6.08% 26.44%
ACRS Aclaris Therapeutics, Inc. Buy 4.71% -2%
MD Pediatrix Medical Group, Inc. Buy 5.04% 4.86%
MDXG MiMedx Group, Inc. Buy 4.75% -1.25%
NVRO Nevro Corp. Buy 5.68% 18.16%
LGND Ligand Pharmaceuticals Incorporated Buy 5.11% 6.35%
AXSM Axsome Therapeutics, Inc. Buy 5.27% 9.54%
CERS Cerus Corporation Buy 5.59% 16.22%
DNLI Denali Therapeutics Inc. Buy 5.19% 7.86%
ATXS Astria Therapeutics, Inc. Buy 4.65% -3.21%
RGNX REGENXBIO Inc. Buy 4.96% 3.09%
ANIP ANI Pharmaceuticals, Inc. Buy 5.14% 6.84%
ORGO Organogenesis Holdings Inc. Buy 5.21% 12.31%
AGEN Agenus Inc. Buy 4.21% -6.01%
SIGA SIGA Technologies, Inc. Buy 3.77% -0.78%
TGTX TG Therapeutics, Inc. Buy 3.81% 0%
The percentage of cash held in the portfolio is: 5.81%
New Assets Added
  • TGTX
Assets Removed
Asset Action Perf %
ESPR Sell All -14.96%
VERU Sell All -24.39%
Assets Rebalanced
None
2025-01-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
AORT Artivion, Inc. Buy 4.82% 1.82%
ESPR Esperion Therapeutics, Inc. Buy 4.46% -5.98%
AXGN AxoGen, Inc. Buy 4.9% 3.51%
INSM Insmed Incorporated Buy 5.39% 13.81%
NUTX Nutex Health Inc. Buy 5.64% 19.09%
ACRS Aclaris Therapeutics, Inc. Buy 4.93% 4%
MD Pediatrix Medical Group, Inc. Buy 4.76% 0.5%
MDXG MiMedx Group, Inc. Buy 4.83% 1.93%
NVRO Nevro Corp. Buy 5.48% 15.57%
LGND Ligand Pharmaceuticals Incorporated Buy 4.98% 5.06%
AXSM Axsome Therapeutics, Inc. Buy 5.17% 9.09%
CERS Cerus Corporation Buy 4.64% -2.16%
DNLI Denali Therapeutics Inc. Buy 5.14% 8.42%
ATXS Astria Therapeutics, Inc. Buy 4.56% -3.72%
RGNX REGENXBIO Inc. Buy 5% 5.51%
ANIP ANI Pharmaceuticals, Inc. Buy 4.87% 2.85%
ORGO Organogenesis Holdings Inc. Buy 4.8% 5.11%
VERU Veru Inc. Buy 5.66% 23.81%
AGEN Agenus Inc. Buy 4.22% -4.44%
SIGA SIGA Technologies, Inc. Buy 3.75% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • SIGA
Assets Removed
Asset Action Perf %
BLUE Sell All -20.97%
Assets Rebalanced
None
2025-01-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
BLUE bluebird bio, Inc. Buy 3.88% -17.94%
AORT Artivion, Inc. Buy 4.94% 4.5%
ESPR Esperion Therapeutics, Inc. Buy 4.35% -8.12%
AXGN AxoGen, Inc. Buy 4.92% 3.95%
INSM Insmed Incorporated Buy 5.27% 11.34%
NUTX Nutex Health Inc. Buy 5.69% 20.31%
ACRS Aclaris Therapeutics, Inc. Buy 4.92% 4%
MD Pediatrix Medical Group, Inc. Buy 4.73% 0%
MDXG MiMedx Group, Inc. Buy 4.9% 3.63%
NVRO Nevro Corp. Buy 5.22% 10.38%
LGND Ligand Pharmaceuticals Incorporated Buy 5.04% 6.42%
AXSM Axsome Therapeutics, Inc. Buy 4.86% 2.59%
CERS Cerus Corporation Buy 4.73% 0%
DNLI Denali Therapeutics Inc. Buy 5.07% 7.16%
ATXS Astria Therapeutics, Inc. Buy 4.6% -2.82%
RGNX REGENXBIO Inc. Buy 4.82% 1.75%
ANIP ANI Pharmaceuticals, Inc. Buy 4.88% 3.18%
ORGO Organogenesis Holdings Inc. Buy 4.84% 6.01%
VERU Veru Inc. Buy 5.92% 29.76%
AGEN Agenus Inc. Buy 4.41% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • AGEN
Assets Removed
Asset Action Perf %
TNDM Sell All -5.5%
Assets Rebalanced
None
2025-01-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 4.91% 0.47%
BLUE bluebird bio, Inc. Buy 4.07% -16.73%
AORT Artivion, Inc. Buy 5.05% 3.34%
ESPR Esperion Therapeutics, Inc. Buy 4.72% -3.42%
AXGN AxoGen, Inc. Buy 4.93% 0.99%
INSM Insmed Incorporated Buy 5.15% 5.54%
NUTX Nutex Health Inc. Buy 5.78% 18.31%
ACRS Aclaris Therapeutics, Inc. Buy 4.9% 0.4%
MD Pediatrix Medical Group, Inc. Buy 4.8% -1.64%
MDXG MiMedx Group, Inc. Buy 5.03% 2.95%
NVRO Nevro Corp. Buy 5.18% 6.13%
LGND Ligand Pharmaceuticals Incorporated Buy 4.92% 0.73%
AXSM Axsome Therapeutics, Inc. Buy 4.88% -0.06%
CERS Cerus Corporation Buy 4.81% -1.62%
DNLI Denali Therapeutics Inc. Buy 4.92% 0.79%
ATXS Astria Therapeutics, Inc. Buy 4.86% -0.51%
RGNX REGENXBIO Inc. Buy 4.69% -3.9%
ANIP ANI Pharmaceuticals, Inc. Buy 4.97% 1.68%
ORGO Organogenesis Holdings Inc. Buy 4.71% 0%
VERU Veru Inc. Buy 4.71% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ORGO
  • VERU
Assets Removed
Asset Action Perf %
MDRX Sell All -6.56%
Assets Rebalanced
None
2025-01-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 4.77% -3.76%
BLUE bluebird bio, Inc. Buy 4.14% -16.43%
MDRX Allscripts Healthcare Solutions, Inc. Buy 4.73% -4.51%
AORT Artivion, Inc. Buy 4.93% -0.56%
ESPR Esperion Therapeutics, Inc. Buy 4.68% -5.56%
AXGN AxoGen, Inc. Buy 5.09% 2.63%
INSM Insmed Incorporated Buy 5.05% 1.84%
NUTX Nutex Health Inc. Buy 5.07% 2.16%
ACRS Aclaris Therapeutics, Inc. Buy 4.98% 0.4%
MD Pediatrix Medical Group, Inc. Buy 4.96% 0%
MDXG MiMedx Group, Inc. Buy 4.96% 0%
NVRO Nevro Corp. Buy 4.96% 0%
LGND Ligand Pharmaceuticals Incorporated Buy 4.96% 0%
AXSM Axsome Therapeutics, Inc. Buy 4.96% 0%
CERS Cerus Corporation Buy 4.96% 0%
DNLI Denali Therapeutics Inc. Buy 4.96% 0%
ATXS Astria Therapeutics, Inc. Buy 4.96% 0%
RGNX REGENXBIO Inc. Buy 4.96% 0%
ANIP ANI Pharmaceuticals, Inc. Buy 4.96% 0%
The percentage of cash held in the portfolio is: 6.96%
New Assets Added
  • MD
  • MDXG
  • NVRO
  • LGND
  • AXSM
  • CERS
  • DNLI
  • ATXS
  • RGNX
  • ANIP
Assets Removed
Asset Action Perf %
ARDX Sell All 0.19%
Assets Rebalanced
None
2025-01-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 4.77% -4.19%
BLUE bluebird bio, Inc. Buy 4.02% -19.25%
MDRX Allscripts Healthcare Solutions, Inc. Buy 4.65% -6.67%
AORT Artivion, Inc. Buy 4.89% -1.82%
ARDX Ardelyx, Inc. Buy 5.24% 5.24%
ESPR Esperion Therapeutics, Inc. Buy 4.77% -4.27%
AXGN AxoGen, Inc. Buy 4.98% -0.05%
INSM Insmed Incorporated Buy 4.93% -0.93%
NUTX Nutex Health Inc. Buy 4.98% 0%
ACRS Aclaris Therapeutics, Inc. Buy 4.98% 0%
The percentage of cash held in the portfolio is: 51.8%
New Assets Added
  • NUTX
  • ACRS
Assets Removed
None
Assets Rebalanced
None
2025-01-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 4.79% -3.07%
BLUE bluebird bio, Inc. Buy 4.23% -14.42%
MDRX Allscripts Healthcare Solutions, Inc. Buy 4.81% -2.56%
AORT Artivion, Inc. Buy 4.79% -2.94%
ARDX Ardelyx, Inc. Buy 5.44% 10.11%
ESPR Esperion Therapeutics, Inc. Buy 4.81% -2.56%
AXGN AxoGen, Inc. Buy 4.94% 0%
INSM Insmed Incorporated Buy 4.94% 0%
The percentage of cash held in the portfolio is: 61.26%
New Assets Added
  • AXGN
  • INSM
Assets Removed
None
Assets Rebalanced
None
2025-01-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 4.79% -3.63%
BLUE bluebird bio, Inc. Buy 4.23% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 4.84% -2.46%
AORT Artivion, Inc. Buy 4.91% -1.16%
ARDX Ardelyx, Inc. Buy 4.72% -5.06%
ESPR Esperion Therapeutics, Inc. Buy 4.97% 0%
The percentage of cash held in the portfolio is: 71.54%
New Assets Added
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2025-01-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 4.96% 0.36%
BLUE bluebird bio, Inc. Buy 4.21% -14.72%
MDRX Allscripts Healthcare Solutions, Inc. Buy 4.82% -2.46%
AORT Artivion, Inc. Buy 4.94% 0%
ARDX Ardelyx, Inc. Buy 4.94% 0%
The percentage of cash held in the portfolio is: 76.12%
New Assets Added
  • AORT
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2025-01-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 4.88% -0.82%
BLUE bluebird bio, Inc. Buy 4.48% -9.07%
MDRX Allscripts Healthcare Solutions, Inc. Buy 4.92% 0%
The percentage of cash held in the portfolio is: 85.71%
New Assets Added
  • MDRX
Assets Removed
None
Assets Rebalanced
None
2025-01-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
TNDM Tandem Diabetes Care, Inc. Buy 4.9% 0%
BLUE bluebird bio, Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 90.2%
New Assets Added
  • TNDM
  • BLUE
Assets Removed
None
Assets Rebalanced
None
2024-12-26 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
PCRX Sell All NA
Assets Rebalanced
None
2024-12-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PCRX Pacira BioSciences, Inc. Buy 5.18% 3.88%
The percentage of cash held in the portfolio is: 94.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All 5.82%
MGNX Sell All -1.76%
Assets Rebalanced
None
2024-12-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.11% 4.2%
MGNX MacroGenics, Inc. Buy 4.92% 0.29%
PCRX Pacira BioSciences, Inc. Buy 5.3% 6.5%
The percentage of cash held in the portfolio is: 84.66%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -13.23%
Assets Rebalanced
None
2024-12-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.18% 7.32%
MGNX MacroGenics, Inc. Buy 4.94% 2.35%
ESPR Esperion Therapeutics, Inc. Buy 6.09% 23.55%
PCRX Pacira BioSciences, Inc. Buy 4.89% 0%
The percentage of cash held in the portfolio is: 78.91%
New Assets Added
None
Assets Removed
Asset Action Perf %
RVNC Sell All -27.34%
Assets Rebalanced
None
2024-12-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5% 4.6%
MGNX MacroGenics, Inc. Buy 4.9% 2.65%
ESPR Esperion Therapeutics, Inc. Buy 5.76% 18.06%
RVNC Revance Therapeutics, Inc. Buy 4.84% 0%
PCRX Pacira BioSciences, Inc. Buy 4.84% 0%
The percentage of cash held in the portfolio is: 74.65%
New Assets Added
  • RVNC
  • PCRX
Assets Removed
Asset Action Perf %
ARWR Sell All -11.63%
Assets Rebalanced
None
2024-12-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.18% 8.55%
MGNX MacroGenics, Inc. Buy 5.18% 8.53%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.8% 0.73%
ESPR Esperion Therapeutics, Inc. Buy 4.87% 0%
The percentage of cash held in the portfolio is: 79.97%
New Assets Added
  • ESPR
Assets Removed
Asset Action Perf %
FATE Sell All -6.62%
Assets Rebalanced
None
2024-12-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 4.96% 3.98%
MGNX MacroGenics, Inc. Buy 5.04% 5.59%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.75% -0.46%
FATE Fate Therapeutics, Inc. Buy 4.77% 0%
The percentage of cash held in the portfolio is: 80.47%
New Assets Added
None
Assets Removed
Asset Action Perf %
ITGR Sell All 2.73%
Assets Rebalanced
None
2024-11-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ITGR Integer Holdings Corporation Buy 4.41% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 4.99% 4.63%
MGNX MacroGenics, Inc. Buy 5.1% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.77% 0%
FATE Fate Therapeutics, Inc. Buy 4.77% 0%
The percentage of cash held in the portfolio is: 75.97%
New Assets Added
None
Assets Removed
Asset Action Perf %
CHRS Sell All NA
Assets Rebalanced
None
2024-11-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
CHRS Coherus BioSciences, Inc. Buy 7.24% 53.66%
ITGR Integer Holdings Corporation Buy 4.41% 2.95%
APLS Apellis Pharmaceuticals, Inc. Buy 4.99% 4.63%
MGNX MacroGenics, Inc. Buy 5.1% 7.06%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.77% 0%
FATE Fate Therapeutics, Inc. Buy 4.77% 0%
The percentage of cash held in the portfolio is: 68.73%
New Assets Added
  • ARWR
  • FATE
Assets Removed
None
Assets Rebalanced
None
2024-11-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
CHRS Coherus BioSciences, Inc. Buy 7.4% 56.1%
ITGR Integer Holdings Corporation Buy 4.37% 1.48%
APLS Apellis Pharmaceuticals, Inc. Buy 4.79% 0%
MGNX MacroGenics, Inc. Buy 4.79% 0%
The percentage of cash held in the portfolio is: 78.66%
New Assets Added
  • APLS
  • MGNX
Assets Removed
None
Assets Rebalanced
None
2024-11-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
CHRS Coherus BioSciences, Inc. Buy 7.02% 47.56%
ITGR Integer Holdings Corporation Buy 4.43% 2.57%
The percentage of cash held in the portfolio is: 88.55%
New Assets Added
None
Assets Removed
Asset Action Perf %
CORT Sell All 17.92%
Assets Rebalanced
None
2024-11-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CORT Corcept Therapeutics Incorporated Buy 4.96% 11.71%
CHRS Coherus BioSciences, Inc. Buy 6.45% 34.15%
ITGR Integer Holdings Corporation Buy 4.34% -0.64%
The percentage of cash held in the portfolio is: 84.26%
New Assets Added
None
Assets Removed
Asset Action Perf %
ATEC Sell All 30.06%
Assets Rebalanced
None
2024-11-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATEC Alphatec Holdings, Inc. Buy 6.1% 26.5%
CORT Corcept Therapeutics Incorporated Buy 4.99% 12.05%
CHRS Coherus BioSciences, Inc. Buy 6.46% 34.15%
ITGR Integer Holdings Corporation Buy 4.27% -2.48%
The percentage of cash held in the portfolio is: 78.19%
New Assets Added
None
Assets Removed
Asset Action Perf %
IRTC Sell All -9.45%
Assets Rebalanced
None
2024-11-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
ATEC Alphatec Holdings, Inc. Buy 5.99% 21.91%
IRTC iRhythm Technologies, Inc. Buy 4.21% -7.33%
CORT Corcept Therapeutics Incorporated Buy 4.92% 8.49%
CHRS Coherus BioSciences, Inc. Buy 4.92% 0.18%
ITGR Integer Holdings Corporation Buy 4.35% -2.37%
The percentage of cash held in the portfolio is: 75.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
NEOG Sell All 5.23%
INCY Sell All -4.56%
MGNX Sell All -10.08%
MDRX Sell All -7.2%
Assets Rebalanced
None
2024-11-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
NEOG Neogen Corporation Buy 5.31% 6%
INCY Incyte Corporation Buy 5.13% 4.11%
ATEC Alphatec Holdings, Inc. Buy 5.35% 8.54%
MGNX MacroGenics, Inc. Buy 4.35% -9.3%
IRTC iRhythm Technologies, Inc. Buy 4.3% -5.62%
CORT Corcept Therapeutics Incorporated Buy 4.79% 5.11%
CHRS Coherus BioSciences, Inc. Buy 4.69% -4.76%
ITGR Integer Holdings Corporation Buy 4.4% -1.63%
MDRX Allscripts Healthcare Solutions, Inc. Buy 3.97% -4.98%
The percentage of cash held in the portfolio is: 57.71%
New Assets Added
None
Assets Removed
Asset Action Perf %
HCSG Sell All 2.56%
AVNS Sell All -8.39%
Assets Rebalanced
None
2024-11-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 5.45% 5.39%
NEOG Neogen Corporation Buy 5.11% 1.81%
INCY Incyte Corporation Buy 5.07% 2.62%
ATEC Alphatec Holdings, Inc. Buy 5.18% 4.84%
MGNX MacroGenics, Inc. Buy 4.43% -7.75%
IRTC iRhythm Technologies, Inc. Buy 4.51% -1.22%
CORT Corcept Therapeutics Incorporated Buy 4.73% 3.54%
AVNS Avanos Medical, Inc. Buy 4.29% -5.56%
CHRS Coherus BioSciences, Inc. Buy 4.48% -9.27%
ITGR Integer Holdings Corporation Buy 4.37% -2.62%
MDRX Allscripts Healthcare Solutions, Inc. Buy 3.96% -5.24%
The percentage of cash held in the portfolio is: 48.4%
New Assets Added
None
Assets Removed
Asset Action Perf %
RGEN Sell All -17.11%
ORMP Sell All -6.3%
Assets Rebalanced
None
2024-11-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 5.49% 8.95%
NEOG Neogen Corporation Buy 4.99% 2.09%
INCY Incyte Corporation Buy 5.06% 5.14%
ATEC Alphatec Holdings, Inc. Buy 5.36% 11.21%
ORMP Oramed Pharmaceuticals Inc. Buy 4.74% -1.68%
MGNX MacroGenics, Inc. Buy 4.61% -1.55%
IRTC iRhythm Technologies, Inc. Buy 4.56% 2.46%
CORT Corcept Therapeutics Incorporated Buy 4.87% 9.45%
AVNS Avanos Medical, Inc. Buy 4.28% -3.19%
CHRS Coherus BioSciences, Inc. Buy 4.54% -5.73%
ITGR Integer Holdings Corporation Buy 4.31% -1.41%
MDRX Allscripts Healthcare Solutions, Inc. Buy 3.92% -3.91%
RGEN Repligen Corporation Buy 5.11% -5.34%
The percentage of cash held in the portfolio is: 38.16%
New Assets Added
None
Assets Removed
Asset Action Perf %
SAGE Sell All -15.03%
ALT Sell All -10.91%
Assets Rebalanced
None
2024-11-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
HCSG Healthcare Services Group, Inc. Buy 5.47% 11.32%
NEOG Neogen Corporation Buy 5.05% 5.86%
INCY Incyte Corporation Buy 5.11% 8.86%
ATEC Alphatec Holdings, Inc. Buy 5.47% 16.31%
ORMP Oramed Pharmaceuticals Inc. Buy 4.58% -2.52%
MGNX MacroGenics, Inc. Buy 4.45% -2.58%
IRTC iRhythm Technologies, Inc. Buy 4.64% 6.99%
CORT Corcept Therapeutics Incorporated Buy 4.89% 12.76%
AVNS Avanos Medical, Inc. Buy 4.25% -1.47%
SAGE Sage Therapeutics, Inc. Buy 4.26% -9.34%
CHRS Coherus BioSciences, Inc. Buy 4.46% -5%
ITGR Integer Holdings Corporation Buy 4.29% 0.58%
MDRX Allscripts Healthcare Solutions, Inc. Buy 3.94% -0.89%
ALT Altimmune, Inc. Buy 5.53% 0.32%
RGEN Repligen Corporation Buy 5.27% 0%
The percentage of cash held in the portfolio is: 28.33%
New Assets Added
  • RGEN
Assets Removed
Asset Action Perf %
CARA Sell All -6.09%
CDMO Sell All 17.76%
Assets Rebalanced
None
2024-11-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
CDMO Avid Bioservices, Inc. Buy 5.06% 18.05%
HCSG Healthcare Services Group, Inc. Buy 5.51% 13.61%
NEOG Neogen Corporation Buy 5.04% 6.97%
INCY Incyte Corporation Buy 5.05% 8.99%
ATEC Alphatec Holdings, Inc. Buy 5.48% 18.22%
ORMP Oramed Pharmaceuticals Inc. Buy 4.56% -1.68%
MGNX MacroGenics, Inc. Buy 4.78% 5.94%
IRTC iRhythm Technologies, Inc. Buy 4.59% 7.07%
CORT Corcept Therapeutics Incorporated Buy 4.94% 15.44%
AVNS Avanos Medical, Inc. Buy 4.28% 0.61%
CARA Cara Therapeutics, Inc. Buy 4.58% -1.16%
SAGE Sage Therapeutics, Inc. Buy 4.2% -9.34%
CHRS Coherus BioSciences, Inc. Buy 4.66% 0.49%
ITGR Integer Holdings Corporation Buy 4.21% 0.1%
MDRX Allscripts Healthcare Solutions, Inc. Buy 3.87% -1.24%
ALT Altimmune, Inc. Buy 5.44% 0%
The percentage of cash held in the portfolio is: 23.75%
New Assets Added
  • ALT
Assets Removed
Asset Action Perf %
AVXL Sell All 36.25%
IBRX Sell All 17.58%
IOVA Sell All -12.15%
NUTX Sell All 51.33%
PTCT Sell All 13.48%
Assets Rebalanced
None
2024-11-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 4.86% 12.45%
PTCT PTC Therapeutics, Inc. Buy 4.93% 14.11%
CDMO Avid Bioservices, Inc. Buy 5.03% 18.24%
IBRX ImmunityBio, Inc. Buy 5.51% 29.45%
HCSG Healthcare Services Group, Inc. Buy 5.36% 11.51%
IOVA Iovance Biotherapeutics, Inc. Buy 4.64% -3.45%
NEOG Neogen Corporation Buy 5.34% 14.37%
INCY Incyte Corporation Buy 5.06% 10.28%
ATEC Alphatec Holdings, Inc. Buy 5.68% 23.57%
AVXL Anavex Life Sciences Corp. Buy 6.35% 38.22%
ORMP Oramed Pharmaceuticals Inc. Buy 4.48% -2.52%
MGNX MacroGenics, Inc. Buy 5.07% 13.44%
IRTC iRhythm Technologies, Inc. Buy 4.64% 9.2%
CORT Corcept Therapeutics Incorporated Buy 5.01% 17.98%
AVNS Avanos Medical, Inc. Buy 4.42% 4.6%
CARA Cara Therapeutics, Inc. Buy 4.54% -1.16%
SAGE Sage Therapeutics, Inc. Buy 4.58% -0.32%
CHRS Coherus BioSciences, Inc. Buy 4.36% -5%
ITGR Integer Holdings Corporation Buy 4.26% 2%
MDRX Allscripts Healthcare Solutions, Inc. Buy 3.89% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • MDRX
Assets Removed
Asset Action Perf %
MCRB Sell All -15.61%
Assets Rebalanced
None
2024-11-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 5.47% 27.16%
PTCT PTC Therapeutics, Inc. Buy 4.84% 12.61%
CDMO Avid Bioservices, Inc. Buy 5.01% 18.34%
IBRX ImmunityBio, Inc. Buy 5.6% 32.3%
HCSG Healthcare Services Group, Inc. Buy 5.19% 8.4%
IOVA Iovance Biotherapeutics, Inc. Buy 4.59% -3.99%
NEOG Neogen Corporation Buy 5.25% 13.18%
INCY Incyte Corporation Buy 5.15% 12.78%
ATEC Alphatec Holdings, Inc. Buy 5.48% 19.75%
AVXL Anavex Life Sciences Corp. Buy 6.38% 39.58%
MCRB Seres Therapeutics, Inc. Buy 3.99% -12.8%
ORMP Oramed Pharmaceuticals Inc. Buy 4.44% -2.94%
MGNX MacroGenics, Inc. Buy 5% 12.4%
IRTC iRhythm Technologies, Inc. Buy 4.49% 6.19%
CORT Corcept Therapeutics Incorporated Buy 5.03% 19.06%
AVNS Avanos Medical, Inc. Buy 4.33% 3.19%
CARA Cara Therapeutics, Inc. Buy 4.5% -1.45%
SAGE Sage Therapeutics, Inc. Buy 4.56% -0.16%
CHRS Coherus BioSciences, Inc. Buy 4.54% -0.61%
ITGR Integer Holdings Corporation Buy 4.15% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ITGR
Assets Removed
Asset Action Perf %
IART Sell All -0.52%
Assets Rebalanced
None
2024-11-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
NUTX Nutex Health Inc. Buy 5.07% 16.4%
PTCT PTC Therapeutics, Inc. Buy 4.76% 9.26%
CDMO Avid Bioservices, Inc. Buy 5.07% 18.15%
IBRX ImmunityBio, Inc. Buy 5.4% 25.89%
HCSG Healthcare Services Group, Inc. Buy 5.21% 7.31%
IOVA Iovance Biotherapeutics, Inc. Buy 5.4% 11.33%
NEOG Neogen Corporation Buy 5.18% 10.04%
INCY Incyte Corporation Buy 5.16% 11.38%
ATEC Alphatec Holdings, Inc. Buy 5.56% 19.87%
AVXL Anavex Life Sciences Corp. Buy 5.35% 15.33%
MCRB Seres Therapeutics, Inc. Buy 4.04% -12.8%
ORMP Oramed Pharmaceuticals Inc. Buy 4.64% 0%
MGNX MacroGenics, Inc. Buy 5.19% 15.25%
IRTC iRhythm Technologies, Inc. Buy 4.67% 8.99%
CORT Corcept Therapeutics Incorporated Buy 4.65% 8.47%
IART Integra LifeSciences Holdings Corporation Buy 4.36% 2.41%
AVNS Avanos Medical, Inc. Buy 4.4% 3.29%
CARA Cara Therapeutics, Inc. Buy 4.63% 0%
SAGE Sage Therapeutics, Inc. Buy 4.63% 0%
CHRS Coherus BioSciences, Inc. Buy 4.63% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • CARA
  • SAGE
  • CHRS
Assets Removed
Asset Action Perf %
NVRO Sell All -1.11%
QDEL Sell All -0.61%
VREX Sell All 17.93%
Assets Rebalanced
None
2024-11-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 5.09% 12.56%
NUTX Nutex Health Inc. Buy 4.56% 0.73%
PTCT PTC Therapeutics, Inc. Buy 4.71% 3.94%
CDMO Avid Bioservices, Inc. Buy 4.53% 1.74%
IBRX ImmunityBio, Inc. Buy 5.76% 29.22%
HCSG Healthcare Services Group, Inc. Buy 5.24% 4.02%
IOVA Iovance Biotherapeutics, Inc. Buy 5.33% 5.71%
NEOG Neogen Corporation Buy 5.12% 4.74%
NVRO Nevro Corp. Buy 4.95% 2.96%
INCY Incyte Corporation Buy 5.03% 4.53%
ATEC Alphatec Holdings, Inc. Buy 5.27% 9.3%
AVXL Anavex Life Sciences Corp. Buy 5.6% 16.31%
MCRB Seres Therapeutics, Inc. Buy 4.77% -0.98%
ORMP Oramed Pharmaceuticals Inc. Buy 4.76% -1.26%
MGNX MacroGenics, Inc. Buy 4.56% -2.58%
IRTC iRhythm Technologies, Inc. Buy 4.74% 6.43%
CORT Corcept Therapeutics Incorporated Buy 4.63% 4.16%
QDEL QuidelOrtho Corporation Buy 4.5% 1.13%
IART Integra LifeSciences Holdings Corporation Buy 4.42% 0%
AVNS Avanos Medical, Inc. Buy 4.42% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • IART
  • AVNS
Assets Removed
None
Assets Rebalanced
None
2024-11-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
VREX Varex Imaging Corporation Buy 5.09% 9.5%
NUTX Nutex Health Inc. Buy 4.31% -7.17%
PTCT PTC Therapeutics, Inc. Buy 4.77% 2.72%
CDMO Avid Bioservices, Inc. Buy 4.56% -0.19%
IBRX ImmunityBio, Inc. Buy 5.65% 23.52%
HCSG Healthcare Services Group, Inc. Buy 5.28% 2.01%
IOVA Iovance Biotherapeutics, Inc. Buy 5.36% 3.72%
NEOG Neogen Corporation Buy 5.05% 0.63%
NVRO Nevro Corp. Buy 4.89% -0.93%
INCY Incyte Corporation Buy 5.06% 2.46%
ATEC Alphatec Holdings, Inc. Buy 5.27% 6.5%
AVXL Anavex Life Sciences Corp. Buy 5.45% 10.27%
MCRB Seres Therapeutics, Inc. Buy 4.87% -1.59%
ORMP Oramed Pharmaceuticals Inc. Buy 4.96% 0.42%
MGNX MacroGenics, Inc. Buy 4.59% -4.39%
IRTC iRhythm Technologies, Inc. Buy 4.57% 0%
CORT Corcept Therapeutics Incorporated Buy 4.57% 0%
QDEL QuidelOrtho Corporation Buy 4.57% 0%
The percentage of cash held in the portfolio is: 11.13%
New Assets Added
  • IRTC
  • CORT
  • QDEL
Assets Removed
Asset Action Perf %
ARWR Sell All 3.62%
VCEL Sell All 5.42%
AXSM Sell All -6.53%
VKTX Sell All -13.77%
Assets Rebalanced
None
2024-11-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.68% 0.67%
VCEL Vericel Corporation Buy 4.86% 4.51%
VREX Varex Imaging Corporation Buy 5.06% 9.09%
AXSM Axsome Therapeutics, Inc. Buy 4.41% -4.83%
NUTX Nutex Health Inc. Buy 4.22% -8.94%
PTCT PTC Therapeutics, Inc. Buy 4.77% 2.92%
CDMO Avid Bioservices, Inc. Buy 4.52% -0.87%
VKTX Viking Therapeutics, Inc. Buy 4.54% -0.46%
IBRX ImmunityBio, Inc. Buy 5.72% 25.42%
HCSG Healthcare Services Group, Inc. Buy 5.26% 1.83%
IOVA Iovance Biotherapeutics, Inc. Buy 5.24% 1.45%
NEOG Neogen Corporation Buy 5.04% 0.7%
NVRO Nevro Corp. Buy 5.05% 2.41%
INCY Incyte Corporation Buy 5.08% 2.98%
ATEC Alphatec Holdings, Inc. Buy 5.1% 3.31%
AVXL Anavex Life Sciences Corp. Buy 5.09% 3.25%
MCRB Seres Therapeutics, Inc. Buy 4.95% 0.24%
ORMP Oramed Pharmaceuticals Inc. Buy 4.81% -2.52%
MGNX MacroGenics, Inc. Buy 4.8% 0%
The percentage of cash held in the portfolio is: 6.8%
New Assets Added
  • MGNX
Assets Removed
Asset Action Perf %
ARDX Sell All 0.83%
Assets Rebalanced
None
2024-11-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.58% -2.81%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.69% -0.67%
VCEL Vericel Corporation Buy 4.94% 4.63%
VREX Varex Imaging Corporation Buy 5.1% 8.51%
AXSM Axsome Therapeutics, Inc. Buy 4.49% -4.63%
NUTX Nutex Health Inc. Buy 4.23% -10.19%
PTCT PTC Therapeutics, Inc. Buy 4.78% 1.53%
CDMO Avid Bioservices, Inc. Buy 4.45% -3.86%
VKTX Viking Therapeutics, Inc. Buy 4.59% -0.93%
IBRX ImmunityBio, Inc. Buy 5.73% 23.75%
HCSG Healthcare Services Group, Inc. Buy 5.25% 0.18%
IOVA Iovance Biotherapeutics, Inc. Buy 4.96% -5.35%
NEOG Neogen Corporation Buy 5.06% -0.42%
NVRO Nevro Corp. Buy 5.1% 2.04%
INCY Incyte Corporation Buy 5.01% 0.26%
ATEC Alphatec Holdings, Inc. Buy 5.01% 0%
AVXL Anavex Life Sciences Corp. Buy 5.01% 0%
MCRB Seres Therapeutics, Inc. Buy 5.01% 0%
ORMP Oramed Pharmaceuticals Inc. Buy 5.01% 0%
The percentage of cash held in the portfolio is: 7.01%
New Assets Added
  • ATEC
  • AVXL
  • MCRB
  • ORMP
Assets Removed
None
Assets Rebalanced
None
2024-10-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.53% -2.48%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.73% 1.81%
VCEL Vericel Corporation Buy 5.03% 8.2%
VREX Varex Imaging Corporation Buy 5.11% 10.33%
AXSM Axsome Therapeutics, Inc. Buy 4.44% -4.17%
NUTX Nutex Health Inc. Buy 4.4% -5.16%
PTCT PTC Therapeutics, Inc. Buy 4.79% 3.41%
CDMO Avid Bioservices, Inc. Buy 4.47% -2.03%
VKTX Viking Therapeutics, Inc. Buy 4.47% -2.01%
IBRX ImmunityBio, Inc. Buy 6.11% 33.97%
HCSG Healthcare Services Group, Inc. Buy 5.21% 0.91%
IOVA Iovance Biotherapeutics, Inc. Buy 5.16% 0.09%
NEOG Neogen Corporation Buy 5.08% 1.6%
NVRO Nevro Corp. Buy 4.92% 0%
INCY Incyte Corporation Buy 4.92% 0%
The percentage of cash held in the portfolio is: 26.62%
New Assets Added
  • NVRO
  • INCY
Assets Removed
Asset Action Perf %
ALGN Sell All -2.57%
Assets Rebalanced
None
2024-10-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.62% -0.5%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.79% 3.2%
VCEL Vericel Corporation Buy 5.05% 8.89%
VREX Varex Imaging Corporation Buy 5.09% 10%
AXSM Axsome Therapeutics, Inc. Buy 4.48% -3.21%
NUTX Nutex Health Inc. Buy 4.12% -10.96%
PTCT PTC Therapeutics, Inc. Buy 5% 8.09%
CDMO Avid Bioservices, Inc. Buy 4.48% -1.74%
ALGN Align Technology, Inc. Buy 4.48% -1.68%
VKTX Viking Therapeutics, Inc. Buy 4.57% 0.18%
IBRX ImmunityBio, Inc. Buy 6.07% 33.25%
HCSG Healthcare Services Group, Inc. Buy 5.19% 0.64%
IOVA Iovance Biotherapeutics, Inc. Buy 5.05% -1.99%
NEOG Neogen Corporation Buy 5% 0%
The percentage of cash held in the portfolio is: 32%
New Assets Added
  • NEOG
Assets Removed
Asset Action Perf %
NKTR Sell All -12.41%
Assets Rebalanced
None
2024-10-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.49% -2.32%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.79% 4.24%
VCEL Vericel Corporation Buy 4.98% 8.48%
VREX Varex Imaging Corporation Buy 4.98% 8.68%
NKTR Nektar Therapeutics Buy 4.3% -6.21%
AXSM Axsome Therapeutics, Inc. Buy 4.42% -3.47%
NUTX Nutex Health Inc. Buy 4.43% -3.3%
PTCT PTC Therapeutics, Inc. Buy 4.72% 2.95%
CDMO Avid Bioservices, Inc. Buy 4.4% -2.51%
ALGN Align Technology, Inc. Buy 4.5% -0.29%
VKTX Viking Therapeutics, Inc. Buy 4.59% 1.78%
IBRX ImmunityBio, Inc. Buy 6.61% 46.56%
HCSG Healthcare Services Group, Inc. Buy 5.1% 0%
IOVA Iovance Biotherapeutics, Inc. Buy 5.1% 0%
The percentage of cash held in the portfolio is: 32.61%
New Assets Added
  • HCSG
  • IOVA
Assets Removed
Asset Action Perf %
SGMO Sell All 110.31%
Assets Rebalanced
None
2024-10-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.56% -4.47%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.95% 3.82%
VCEL Vericel Corporation Buy 4.96% 3.94%
SGMO Sangamo Therapeutics, Inc. Buy 7.37% 54.64%
VREX Varex Imaging Corporation Buy 5.07% 6.69%
NKTR Nektar Therapeutics Buy 4.33% -8.97%
AXSM Axsome Therapeutics, Inc. Buy 4.58% -3.73%
NUTX Nutex Health Inc. Buy 4.66% -2.14%
PTCT PTC Therapeutics, Inc. Buy 4.93% 3.64%
CDMO Avid Bioservices, Inc. Buy 4.52% -3.47%
ALGN Align Technology, Inc. Buy 4.75% 1.33%
VKTX Viking Therapeutics, Inc. Buy 4.99% 6.57%
IBRX ImmunityBio, Inc. Buy 5.92% 26.37%
The percentage of cash held in the portfolio is: 34.42%
New Assets Added
None
Assets Removed
Asset Action Perf %
ORGO Sell All -9.09%
Assets Rebalanced
None
2024-10-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 4.52% -6.82%
ARDX Ardelyx, Inc. Buy 4.69% -2.98%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.98% 2.94%
VCEL Vericel Corporation Buy 4.93% 1.85%
SGMO Sangamo Therapeutics, Inc. Buy 7.43% 53.61%
VREX Varex Imaging Corporation Buy 5.11% 5.95%
NKTR Nektar Therapeutics Buy 4.49% -6.9%
AXSM Axsome Therapeutics, Inc. Buy 4.59% -4.84%
NUTX Nutex Health Inc. Buy 4.78% -0.97%
PTCT PTC Therapeutics, Inc. Buy 5.08% 5.29%
CDMO Avid Bioservices, Inc. Buy 4.68% -1.45%
ALGN Align Technology, Inc. Buy 4.75% 0%
VKTX Viking Therapeutics, Inc. Buy 4.75% 0%
IBRX ImmunityBio, Inc. Buy 4.75% 0%
The percentage of cash held in the portfolio is: 30.49%
New Assets Added
  • ALGN
  • VKTX
  • IBRX
Assets Removed
None
Assets Rebalanced
None
2024-10-24 00:00:00 : Portfolio change date
Asset Action Weight PnL
ORGO Organogenesis Holdings Inc. Buy 4.54% -6.17%
ARDX Ardelyx, Inc. Buy 4.45% -7.62%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.96% 2.89%
VCEL Vericel Corporation Buy 4.84% 0.45%
SGMO Sangamo Therapeutics, Inc. Buy 7.65% 58.76%
VREX Varex Imaging Corporation Buy 5.06% 5.37%
NKTR Nektar Therapeutics Buy 4.67% -2.76%
AXSM Axsome Therapeutics, Inc. Buy 4.75% -1.1%
NUTX Nutex Health Inc. Buy 4.57% -4.88%
PTCT PTC Therapeutics, Inc. Buy 5.19% 8.04%
CDMO Avid Bioservices, Inc. Buy 4.73% 0%
The percentage of cash held in the portfolio is: 44.58%
New Assets Added
  • CDMO
Assets Removed
Asset Action Perf %
IRWD Sell All -6.57%
CDXS Sell All -9.73%
Assets Rebalanced
None
2024-10-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.67% -4.23%
ORGO Organogenesis Holdings Inc. Buy 4.9% 0.65%
ARDX Ardelyx, Inc. Buy 4.65% -4.3%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.11% 5.27%
VCEL Vericel Corporation Buy 4.83% -0.62%
CDXS Codexis, Inc. Buy 4.73% -2.65%
SGMO Sangamo Therapeutics, Inc. Buy 6.06% 24.74%
VREX Varex Imaging Corporation Buy 5.02% 3.64%
NKTR Nektar Therapeutics Buy 4.81% -0.69%
AXSM Axsome Therapeutics, Inc. Buy 4.79% -1.02%
NUTX Nutex Health Inc. Buy 4.84% 0%
PTCT PTC Therapeutics, Inc. Buy 4.84% 0%
The percentage of cash held in the portfolio is: 40.75%
New Assets Added
  • NUTX
  • PTCT
Assets Removed
Asset Action Perf %
LXRX Sell All -3.48%
Assets Rebalanced
None
2024-10-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.87% -1.64%
ORGO Organogenesis Holdings Inc. Buy 4.99% 0.97%
ARDX Ardelyx, Inc. Buy 4.8% -2.65%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.22% 5.84%
VCEL Vericel Corporation Buy 4.82% -2.16%
CDXS Codexis, Inc. Buy 4.78% -2.95%
SGMO Sangamo Therapeutics, Inc. Buy 4.62% -6.19%
VREX Varex Imaging Corporation Buy 5.12% 4.13%
NKTR Nektar Therapeutics Buy 4.71% -4.14%
LXRX Lexicon Pharmaceuticals, Inc. Buy 4.77% -2.99%
AXSM Axsome Therapeutics, Inc. Buy 4.82% -1.98%
The percentage of cash held in the portfolio is: 46.47%
New Assets Added
None
Assets Removed
Asset Action Perf %
BKD Sell All 3.8%
Assets Rebalanced
None
2024-10-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.1% 4.23%
ORGO Organogenesis Holdings Inc. Buy 4.88% -0.32%
ARDX Ardelyx, Inc. Buy 4.71% -3.48%
BKD Brookdale Senior Living Inc. Buy 5.33% 9.26%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.25% 7.64%
VCEL Vericel Corporation Buy 4.72% -3.37%
CDXS Codexis, Inc. Buy 4.85% -0.59%
SGMO Sangamo Therapeutics, Inc. Buy 4.73% -3.09%
VREX Varex Imaging Corporation Buy 4.87% 0%
NKTR Nektar Therapeutics Buy 4.87% 0%
LXRX Lexicon Pharmaceuticals, Inc. Buy 4.87% 0%
AXSM Axsome Therapeutics, Inc. Buy 4.87% 0%
The percentage of cash held in the portfolio is: 40.94%
New Assets Added
  • VREX
  • NKTR
  • LXRX
  • AXSM
Assets Removed
Asset Action Perf %
RDNT Sell All -3.2%
Assets Rebalanced
None
2024-10-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 5.04% 3.05%
ORGO Organogenesis Holdings Inc. Buy 5.08% 3.9%
ARDX Ardelyx, Inc. Buy 4.82% -1.16%
BKD Brookdale Senior Living Inc. Buy 4.89% 0.33%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 5.01% 2.69%
VCEL Vericel Corporation Buy 4.86% -0.33%
RDNT RadNet, Inc. Buy 4.89% 0.2%
CDXS Codexis, Inc. Buy 4.88% 0%
SGMO Sangamo Therapeutics, Inc. Buy 4.88% 0%
The percentage of cash held in the portfolio is: 55.65%
New Assets Added
  • CDXS
  • SGMO
Assets Removed
None
Assets Rebalanced
None
2024-10-15 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.95% 0.7%
ORGO Organogenesis Holdings Inc. Buy 4.93% 0.32%
ARDX Ardelyx, Inc. Buy 4.86% -0.83%
BKD Brookdale Senior Living Inc. Buy 4.9% 0%
ARWR Arrowhead Pharmaceuticals, Inc. Buy 4.9% 0%
VCEL Vericel Corporation Buy 4.9% 0%
RDNT RadNet, Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 65.67%
New Assets Added
  • BKD
  • ARWR
  • VCEL
  • RDNT
Assets Removed
None
Assets Rebalanced
None
2024-10-14 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.92% 0%
ORGO Organogenesis Holdings Inc. Buy 4.9% -0.32%
ARDX Ardelyx, Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 85.29%
New Assets Added
  • ARDX
Assets Removed
None
Assets Rebalanced
None
2024-10-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.86% -1.17%
ORGO Organogenesis Holdings Inc. Buy 4.83% -1.95%
The percentage of cash held in the portfolio is: 90.31%
New Assets Added
None
Assets Removed
Asset Action Perf %
BCRX Sell All -6.07%
Assets Rebalanced
None
2024-10-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.94% 0.94%
BCRX BioCryst Pharmaceuticals, Inc. Buy 4.9% 0%
ORGO Organogenesis Holdings Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 85.26%
New Assets Added
  • BCRX
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-10-03 00:00:00 : Portfolio change date
Asset Action Weight PnL
IRWD Ironwood Pharmaceuticals, Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 95.1%
New Assets Added
  • IRWD
Assets Removed
None
Assets Rebalanced
None
2024-09-26 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
NVCR Sell All -11.63%
Assets Rebalanced
None
2024-09-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 4.36% -8.98%
The percentage of cash held in the portfolio is: 95.64%
New Assets Added
None
Assets Removed
Asset Action Perf %
MYGN Sell All -1.56%
Assets Rebalanced
None
2024-09-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
NVCR NovoCure Limited Buy 4.61% -3.32%
MYGN Myriad Genetics, Inc. Buy 4.84% 2.48%
The percentage of cash held in the portfolio is: 90.56%
New Assets Added
None
Assets Removed
Asset Action Perf %
ESPR Sell All -8.2%
Assets Rebalanced
None
2024-09-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
ESPR Esperion Therapeutics, Inc. Buy 4.67% -4.92%
NVCR NovoCure Limited Buy 4.63% -2.44%
MYGN Myriad Genetics, Inc. Buy 4.96% 5.56%
The percentage of cash held in the portfolio is: 85.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
PODD Sell All 15.5%
Assets Rebalanced
None
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PODD Insulet Corporation Buy 5.63% 14.42%
ESPR Esperion Therapeutics, Inc. Buy 4.73% -3.83%
NVCR NovoCure Limited Buy 4.72% -0.5%
MYGN Myriad Genetics, Inc. Buy 4.86% 3.45%
The percentage of cash held in the portfolio is: 80.06%
New Assets Added
None
Assets Removed
Asset Action Perf %
MGNX Sell All -2.28%
AADI Sell All 7.43%
TVTX Sell All 48.65%
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
AADI Aadi Bioscience, Inc. Buy 5.04% 1.14%
PODD Insulet Corporation Buy 5.62% 12.73%
MGNX MacroGenics, Inc. Buy 5.13% 2.85%
ESPR Esperion Therapeutics, Inc. Buy 4.77% -4.37%
TVTX Travere Therapeutics, Inc. Buy 6.44% 31.25%
NVCR NovoCure Limited Buy 4.62% -3.99%
MYGN Myriad Genetics, Inc. Buy 4.67% -2.15%
The percentage of cash held in the portfolio is: 63.7%
New Assets Added
None
Assets Removed
Asset Action Perf %
AGEN Sell All 8.41%
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
AGEN Agenus Inc. Buy 5.16% 3.11%
AADI Aadi Bioscience, Inc. Buy 5.26% 5.14%
PODD Insulet Corporation Buy 5.58% 11.4%
MGNX MacroGenics, Inc. Buy 5.16% 3.13%
ESPR Esperion Therapeutics, Inc. Buy 4.76% -4.92%
TVTX Travere Therapeutics, Inc. Buy 6.28% 27.5%
NVCR NovoCure Limited Buy 4.61% -4.54%
MYGN Myriad Genetics, Inc. Buy 4.67% -2.56%
The percentage of cash held in the portfolio is: 58.51%
New Assets Added
None
Assets Removed
Asset Action Perf %
APLS Sell All -3.75%
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 4.92% -1.69%
AGEN Agenus Inc. Buy 5% -0.18%
AADI Aadi Bioscience, Inc. Buy 5.09% 1.71%
PODD Insulet Corporation Buy 5.55% 10.8%
MGNX MacroGenics, Inc. Buy 5.08% 1.42%
ESPR Esperion Therapeutics, Inc. Buy 4.73% -5.46%
TVTX Travere Therapeutics, Inc. Buy 6.59% 33.75%
NVCR NovoCure Limited Buy 4.53% -6.37%
MYGN Myriad Genetics, Inc. Buy 4.8% 0.26%
The percentage of cash held in the portfolio is: 53.71%
New Assets Added
None
Assets Removed
Asset Action Perf %
CARA Sell All -18.08%
Assets Rebalanced
None
2024-09-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.03% 0.21%
CARA Cara Therapeutics, Inc. Buy 4.53% -9.62%
AGEN Agenus Inc. Buy 4.7% -6.22%
AADI Aadi Bioscience, Inc. Buy 5.19% 3.43%
PODD Insulet Corporation Buy 5.38% 7.2%
MGNX MacroGenics, Inc. Buy 4.93% -1.71%
ESPR Esperion Therapeutics, Inc. Buy 4.66% -7.1%
TVTX Travere Therapeutics, Inc. Buy 6.61% 33.96%
NVCR NovoCure Limited Buy 4.46% -7.98%
MYGN Myriad Genetics, Inc. Buy 4.83% 0.63%
The percentage of cash held in the portfolio is: 49.69%
New Assets Added
None
Assets Removed
Asset Action Perf %
ALDX Sell All -6.49%
Assets Rebalanced
None
2024-09-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 5.22% 3%
CARA Cara Therapeutics, Inc. Buy 4.76% -6.12%
AGEN Agenus Inc. Buy 4.59% -9.51%
AADI Aadi Bioscience, Inc. Buy 5.3% 4.57%
PODD Insulet Corporation Buy 5.33% 5.05%
MGNX MacroGenics, Inc. Buy 4.7% -7.41%
ESPR Esperion Therapeutics, Inc. Buy 4.57% -9.84%
TVTX Travere Therapeutics, Inc. Buy 5.7% 14.37%
ALDX Aldeyra Therapeutics, Inc. Buy 4.75% -3.01%
NVCR NovoCure Limited Buy 4.58% -6.48%
MYGN Myriad Genetics, Inc. Buy 4.85% 0%
The percentage of cash held in the portfolio is: 45.65%
New Assets Added
  • MYGN
Assets Removed
Asset Action Perf %
ORGO Sell All -12.72%
Assets Rebalanced
None
2024-09-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 4.98% -1.42%
ORGO Organogenesis Holdings Inc. Buy 4.71% -6.71%
CARA Cara Therapeutics, Inc. Buy 4.73% -6.41%
AGEN Agenus Inc. Buy 4.62% -8.59%
AADI Aadi Bioscience, Inc. Buy 5.2% 2.86%
PODD Insulet Corporation Buy 5.34% 5.72%
MGNX MacroGenics, Inc. Buy 4.87% -3.7%
ESPR Esperion Therapeutics, Inc. Buy 4.75% -6.01%
TVTX Travere Therapeutics, Inc. Buy 5.14% 3.44%
ALDX Aldeyra Therapeutics, Inc. Buy 4.88% 0%
NVCR NovoCure Limited Buy 4.88% 0%
The percentage of cash held in the portfolio is: 45.91%
New Assets Added
  • NVCR
Assets Removed
None
Assets Rebalanced
None
2024-09-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 4.79% -5.21%
ORGO Organogenesis Holdings Inc. Buy 4.82% -4.59%
CARA Cara Therapeutics, Inc. Buy 4.75% -6.12%
AGEN Agenus Inc. Buy 4.48% -11.33%
AADI Aadi Bioscience, Inc. Buy 5.2% 2.86%
PODD Insulet Corporation Buy 5.26% 3.96%
MGNX MacroGenics, Inc. Buy 4.78% -5.41%
ESPR Esperion Therapeutics, Inc. Buy 5.03% -0.55%
TVTX Travere Therapeutics, Inc. Buy 5.2% 4.69%
ALDX Aldeyra Therapeutics, Inc. Buy 4.88% 0%
The percentage of cash held in the portfolio is: 50.81%
New Assets Added
  • ALDX
Assets Removed
Asset Action Perf %
CERS Sell All -11.34%
EGRX Sell All -11.35%
Assets Rebalanced
None
2024-09-04 00:00:00 : Portfolio change date
Asset Action Weight PnL
APLS Apellis Pharmaceuticals, Inc. Buy 4.92% -2.65%
ORGO Organogenesis Holdings Inc. Buy 4.87% -3.53%
CARA Cara Therapeutics, Inc. Buy 4.88% -3.5%
AGEN Agenus Inc. Buy 4.57% -9.51%
CERS Cerus Corporation Buy 4.65% -7.98%
AADI Aadi Bioscience, Inc. Buy 5.02% -0.57%
PODD Insulet Corporation Buy 5.11% 1.11%
EGRX Eagle Pharmaceuticals, Inc. Buy 4.53% -10.38%
MGNX MacroGenics, Inc. Buy 4.72% -6.55%
ESPR Esperion Therapeutics, Inc. Buy 5.05% 0%
TVTX Travere Therapeutics, Inc. Buy 4.97% 0%
The percentage of cash held in the portfolio is: 46.71%
New Assets Added
  • TVTX
Assets Removed
Asset Action Perf %
ARDX Sell All -11.62%
NEOG Sell All -6.34%
Assets Rebalanced
None
2024-09-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.77% -2.98%
APLS Apellis Pharmaceuticals, Inc. Buy 4.8% -2.4%
ORGO Organogenesis Holdings Inc. Buy 5.01% 1.77%
CARA Cara Therapeutics, Inc. Buy 5.16% 4.96%
AGEN Agenus Inc. Buy 4.63% -5.85%
CERS Cerus Corporation Buy 4.67% -5.04%
AADI Aadi Bioscience, Inc. Buy 5.09% 3.43%
NEOG Neogen Corporation Buy 4.94% 0.35%
PODD Insulet Corporation Buy 4.88% -0.81%
EGRX Eagle Pharmaceuticals, Inc. Buy 4.86% -1.15%
MGNX MacroGenics, Inc. Buy 4.92% 0%
ESPR Esperion Therapeutics, Inc. Buy 4.92% 0%
The percentage of cash held in the portfolio is: 41.35%
New Assets Added
  • MGNX
  • ESPR
Assets Removed
None
Assets Rebalanced
None
2024-08-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.78% -3.45%
APLS Apellis Pharmaceuticals, Inc. Buy 4.74% -4.2%
ORGO Organogenesis Holdings Inc. Buy 5.12% 3.53%
CARA Cara Therapeutics, Inc. Buy 5.13% 3.79%
AGEN Agenus Inc. Buy 4.62% -6.58%
CERS Cerus Corporation Buy 4.65% -5.88%
AADI Aadi Bioscience, Inc. Buy 4.75% -4%
NEOG Neogen Corporation Buy 4.84% -2.15%
PODD Insulet Corporation Buy 4.95% 0%
EGRX Eagle Pharmaceuticals, Inc. Buy 4.95% 0%
The percentage of cash held in the portfolio is: 51.48%
New Assets Added
  • PODD
  • EGRX
Assets Removed
None
Assets Rebalanced
None
2024-08-28 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.78% -2.35%
APLS Apellis Pharmaceuticals, Inc. Buy 4.86% -0.64%
ORGO Organogenesis Holdings Inc. Buy 5.09% 3.89%
CARA Cara Therapeutics, Inc. Buy 5.12% 4.66%
AGEN Agenus Inc. Buy 5.04% 2.93%
CERS Cerus Corporation Buy 4.77% -2.52%
AADI Aadi Bioscience, Inc. Buy 4.7% -4%
NEOG Neogen Corporation Buy 4.9% 0%
The percentage of cash held in the portfolio is: 60.74%
New Assets Added
  • NEOG
Assets Removed
None
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.8% -0.94%
APLS Apellis Pharmaceuticals, Inc. Buy 4.85% -0.05%
ORGO Organogenesis Holdings Inc. Buy 5.19% 7.07%
CARA Cara Therapeutics, Inc. Buy 5.23% 7.87%
AGEN Agenus Inc. Buy 5.2% 7.31%
CERS Cerus Corporation Buy 4.85% 0%
AADI Aadi Bioscience, Inc. Buy 4.85% 0%
The percentage of cash held in the portfolio is: 65.02%
New Assets Added
  • CERS
  • AADI
Assets Removed
None
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.68% -5.02%
APLS Apellis Pharmaceuticals, Inc. Buy 4.83% -1.79%
ORGO Organogenesis Holdings Inc. Buy 4.78% -2.83%
CARA Cara Therapeutics, Inc. Buy 4.92% 0%
AGEN Agenus Inc. Buy 4.92% 0%
The percentage of cash held in the portfolio is: 75.86%
New Assets Added
  • CARA
  • AGEN
Assets Removed
None
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ARDX Ardelyx, Inc. Buy 4.9% 0%
APLS Apellis Pharmaceuticals, Inc. Buy 4.9% 0%
ORGO Organogenesis Holdings Inc. Buy 4.9% 0%
The percentage of cash held in the portfolio is: 85.3%
New Assets Added
  • ARDX
  • APLS
  • ORGO
Assets Removed
None
Assets Rebalanced
None
2024-08-19 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
CYH Sell All -1.57%
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
CYH Community Health Systems, Inc. Buy 4.29% -7.66%
The percentage of cash held in the portfolio is: 95.71%
New Assets Added
None
Assets Removed
Asset Action Perf %
RMD Sell All 1.39%
RCM Sell All 7.14%
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 4.82% 7.06%
CYH Community Health Systems, Inc. Buy 4.39% -5.3%
RMD ResMed Inc. Buy 4.43% 3.67%
The percentage of cash held in the portfolio is: 86.36%
New Assets Added
None
Assets Removed
Asset Action Perf %
BKD Sell All -5.42%
FATE Sell All 7.71%
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
BKD Brookdale Senior Living Inc. Buy 5.69% -1.06%
FATE Fate Therapeutics, Inc. Buy 6.84% 19.02%
RCM R1 RCM Inc. Buy 4.79% 7.83%
CYH Community Health Systems, Inc. Buy 4.49% -1.96%
RMD ResMed Inc. Buy 4.54% 7.5%
The percentage of cash held in the portfolio is: 73.66%
New Assets Added
None
Assets Removed
Asset Action Perf %
MASI Sell All -5.02%
HQY Sell All -11.82%
SAVA Sell All 95.11%
SAGE Sell All -12.65%
HCSG Sell All -6.49%
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
MASI Masimo Corporation Buy 4.22% -4.14%
BKD Brookdale Senior Living Inc. Buy 5.85% 1.06%
FATE Fate Therapeutics, Inc. Buy 7.27% 25.45%
RCM R1 RCM Inc. Buy 4.86% 8.44%
CYH Community Health Systems, Inc. Buy 4.54% -1.57%
HQY HealthEquity, Inc. Buy 4.44% -3.84%
SAVA Cassava Sciences, Inc. Buy 7.27% 57.44%
SAGE Sage Therapeutics, Inc. Buy 4.1% -11.19%
HCSG Healthcare Services Group, Inc. Buy 4.3% -3.72%
RMD ResMed Inc. Buy 4.39% 3.13%
The percentage of cash held in the portfolio is: 48.76%
New Assets Added
None
Assets Removed
Asset Action Perf %
ANGO Sell All 27.08%
SGRY Sell All 18.28%
AVNS Sell All 12.13%
CUTR Sell All -12.16%
RGNX Sell All 4.72%
SUPN Sell All 3.79%
Assets Rebalanced
None
2024-08-01 00:00:00 : Portfolio change date
Asset Action Weight PnL
ANGO AngioDynamics, Inc. Buy 5.59% 27.9%
SGRY Surgery Partners, Inc. Buy 5.19% 18.83%
AVNS Avanos Medical, Inc. Buy 4.93% 12.94%
CUTR Cutera, Inc. Buy 4.13% -5.41%
RGNX REGENXBIO Inc. Buy 4.9% 12.12%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.57% 4.67%
MASI Masimo Corporation Buy 4.15% -4.45%
BKD Brookdale Senior Living Inc. Buy 5.83% 2.25%
FATE Fate Therapeutics, Inc. Buy 7.82% 37.02%
RCM R1 RCM Inc. Buy 4.36% -1.15%
CYH Community Health Systems, Inc. Buy 4.7% 3.34%
HQY HealthEquity, Inc. Buy 4.41% -3.09%
SAVA Cassava Sciences, Inc. Buy 6.77% 48.93%
SAGE Sage Therapeutics, Inc. Buy 4.53% -0.36%
HCSG Healthcare Services Group, Inc. Buy 4.35% -1.12%
RMD ResMed Inc. Buy 4.3% 2.5%
The percentage of cash held in the portfolio is: 19.47%
New Assets Added
None
Assets Removed
Asset Action Perf %
PDSB Sell All 1.14%
OPK Sell All 7.58%
Assets Rebalanced
None
2024-07-31 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.38% -1.7%
OPK OPKO Health, Inc. Buy 4.83% 8.33%
ANGO AngioDynamics, Inc. Buy 5.68% 27.73%
SGRY Surgery Partners, Inc. Buy 5.44% 22.27%
AVNS Avanos Medical, Inc. Buy 4.82% 8.4%
CUTR Cutera, Inc. Buy 4.33% -2.7%
RGNX REGENXBIO Inc. Buy 5% 12.43%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.73% 6.28%
MASI Masimo Corporation Buy 4.2% -4.93%
BKD Brookdale Senior Living Inc. Buy 6.01% 3.44%
FATE Fate Therapeutics, Inc. Buy 7.66% 31.88%
RCM R1 RCM Inc. Buy 4.45% -1%
CYH Community Health Systems, Inc. Buy 4.7% 1.38%
HQY HealthEquity, Inc. Buy 4.49% -3.16%
SAVA Cassava Sciences, Inc. Buy 5.46% 17.76%
SAGE Sage Therapeutics, Inc. Buy 4.55% -1.73%
HCSG Healthcare Services Group, Inc. Buy 4.46% -0.43%
RMD ResMed Inc. Buy 4.27% 0%
The percentage of cash held in the portfolio is: 10.54%
New Assets Added
  • RMD
Assets Removed
Asset Action Perf %
SMTI Sell All -8.69%
CLDX Sell All -12.36%
Assets Rebalanced
None
2024-07-30 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.76% 8.52%
OPK OPKO Health, Inc. Buy 4.76% 8.33%
ANGO AngioDynamics, Inc. Buy 5.48% 24.96%
SGRY Surgery Partners, Inc. Buy 5.34% 21.76%
AVNS Avanos Medical, Inc. Buy 4.74% 8.03%
CUTR Cutera, Inc. Buy 4.15% -5.41%
RGNX REGENXBIO Inc. Buy 4.95% 12.9%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.71% 7.37%
MASI Masimo Corporation Buy 4.21% -3.46%
BKD Brookdale Senior Living Inc. Buy 5.98% 4.37%
FATE Fate Therapeutics, Inc. Buy 7.96% 39.07%
RCM R1 RCM Inc. Buy 4.31% -2.61%
CLDX Celldex Therapeutics, Inc. Buy 4.38% -4.26%
SMTI Sanara MedTech Inc. Buy 4.32% -5.45%
CYH Community Health Systems, Inc. Buy 4.65% 1.77%
HQY HealthEquity, Inc. Buy 4.49% -1.69%
SAVA Cassava Sciences, Inc. Buy 5.51% 20.78%
SAGE Sage Therapeutics, Inc. Buy 4.49% -1.64%
HCSG Healthcare Services Group, Inc. Buy 4.41% 0%
The percentage of cash held in the portfolio is: 6.41%
New Assets Added
  • HCSG
Assets Removed
Asset Action Perf %
PTGX Sell All -7.35%
Assets Rebalanced
None
2024-07-29 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.8% 10.23%
OPK OPKO Health, Inc. Buy 4.88% 12.12%
ANGO AngioDynamics, Inc. Buy 5.42% 24.8%
SGRY Surgery Partners, Inc. Buy 5.45% 25.32%
AVNS Avanos Medical, Inc. Buy 4.75% 9.25%
CUTR Cutera, Inc. Buy 4.46% 2.7%
RGNX REGENXBIO Inc. Buy 4.9% 12.75%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.69% 7.93%
MASI Masimo Corporation Buy 4.2% -2.65%
BKD Brookdale Senior Living Inc. Buy 6% 5.69%
FATE Fate Therapeutics, Inc. Buy 7.94% 39.85%
RCM R1 RCM Inc. Buy 4.38% -0.19%
PTGX Protagonist Therapeutics, Inc. Buy 4.36% -3.84%
CLDX Celldex Therapeutics, Inc. Buy 4.61% 1.6%
SMTI Sanara MedTech Inc. Buy 4.53% 0%
CYH Community Health Systems, Inc. Buy 4.53% 0%
HQY HealthEquity, Inc. Buy 4.53% 0%
SAVA Cassava Sciences, Inc. Buy 4.53% 0%
SAGE Sage Therapeutics, Inc. Buy 4.53% 0%
The percentage of cash held in the portfolio is: 6.53%
New Assets Added
  • SMTI
  • CYH
  • HQY
  • SAVA
  • SAGE
Assets Removed
Asset Action Perf %
ATRC Sell All -12.65%
Assets Rebalanced
None
2024-07-26 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.9% 11.93%
OPK OPKO Health, Inc. Buy 4.71% 7.58%
ANGO AngioDynamics, Inc. Buy 5.36% 22.51%
SGRY Surgery Partners, Inc. Buy 5.27% 20.35%
AVNS Avanos Medical, Inc. Buy 4.73% 8.22%
CUTR Cutera, Inc. Buy 4.14% -5.41%
RGNX REGENXBIO Inc. Buy 4.95% 13.22%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.71% 7.69%
MASI Masimo Corporation Buy 4.26% -1.95%
BKD Brookdale Senior Living Inc. Buy 5.91% 3.44%
FATE Fate Therapeutics, Inc. Buy 7.93% 38.82%
ATRC AtriCure, Inc. Buy 4.81% -7%
RCM R1 RCM Inc. Buy 4.38% -0.84%
PTGX Protagonist Therapeutics, Inc. Buy 4.53% -0.76%
CLDX Celldex Therapeutics, Inc. Buy 4.57% 0%
The percentage of cash held in the portfolio is: 24.83%
New Assets Added
  • CLDX
Assets Removed
None
Assets Rebalanced
None
2024-07-25 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.73% 6.96%
OPK OPKO Health, Inc. Buy 4.75% 7.58%
ANGO AngioDynamics, Inc. Buy 5.28% 19.58%
SGRY Surgery Partners, Inc. Buy 5.13% 16.16%
AVNS Avanos Medical, Inc. Buy 4.71% 6.7%
CUTR Cutera, Inc. Buy 4.3% -2.7%
RGNX REGENXBIO Inc. Buy 4.74% 7.32%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.72% 6.84%
MASI Masimo Corporation Buy 4.28% -2.4%
BKD Brookdale Senior Living Inc. Buy 5.98% 3.7%
FATE Fate Therapeutics, Inc. Buy 7.68% 33.16%
ATRC AtriCure, Inc. Buy 4.94% -5.18%
RCM R1 RCM Inc. Buy 4.5% 0.92%
PTGX Protagonist Therapeutics, Inc. Buy 4.61% 0%
The percentage of cash held in the portfolio is: 29.66%
New Assets Added
  • PTGX
Assets Removed
Asset Action Perf %
SAGE Sell All -11.55%
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 4.9% 10.8%
OPK OPKO Health, Inc. Buy 4.89% 10.61%
ANGO AngioDynamics, Inc. Buy 5.14% 16.31%
SGRY Surgery Partners, Inc. Buy 4.87% 10.29%
AVNS Avanos Medical, Inc. Buy 4.69% 6.28%
CUTR Cutera, Inc. Buy 4.86% 10.14%
RGNX REGENXBIO Inc. Buy 4.44% 0.47%
SAGE Sage Therapeutics, Inc. Buy 4.82% 9.08%
SUPN Supernus Pharmaceuticals, Inc. Buy 4.65% 5.3%
MASI Masimo Corporation Buy 4.21% -4.03%
BKD Brookdale Senior Living Inc. Buy 5.93% 2.78%
FATE Fate Therapeutics, Inc. Buy 6.76% 17.22%
ATRC AtriCure, Inc. Buy 4.91% -5.85%
RCM R1 RCM Inc. Buy 4.56% 2.15%
The percentage of cash held in the portfolio is: 30.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
VRDN Sell All 13.4%
RYTM Sell All 16.66%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings